• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Biologics

The latest biologics news — tracking drug development, clinical milestones, regulatory approvals, and deals across the fast-moving world of biologic medicines.

Brought to you by:
Thermo Fisher Scientific
FDA
Biotech

Capricor secures reprieve as FDA extends DMD cell therapy review

The FDA deferred its decision to review information the biotech submitted after a negative advisory committee vote.
Nick Paul Taylor Aug 25, 2026 3:26am
Dont cross signal on city street

Regenxbio gene therapy refiling plan derailed by FDA hold

Aug 24, 2026 7:51am
fired layoffs cut executives dismissed

Kolon TissueGene shrinks workforce after pivotal trial miss

Aug 18, 2026 4:00pm
Gene editing CRISPR gene therapy

After 2 undisclosed deaths, can China’s IIT still be trusted?

Aug 17, 2026 7:20am
pivot change turnaround direction walk away

Capricor soars on plan to amend DMD filing after adcomm setback

Aug 14, 2026 10:20am
sold

PTC bets $211M on ‘special opportunity’ to enter Fabry market

Aug 13, 2026 8:15am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings